Effective treatment of severe COVID-19 patients with tocilizumab

After analyzing the immune characteristics of patients with severe coronavirus disease 2019 (COVID-19), we have identified that pathogenic T cells and inflammatory monocytes with large amount of interleukin 6 secreting may incite the inflammatory storm, which may potentially be curbed through monocl...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiaoling, Han, Mingfeng, Li, Tiantian, Sun, Wei, Wang, Dongsheng, Fu, Binqing, Zhou, Yonggang, Zheng, Xiaohu, Yang, Yun, Li, Xiuyong, Zhang, Xiaohua, Pan, Aijun, Wei, Haiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2020
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245089/
https://www.ncbi.nlm.nih.gov/pubmed/32350134
http://dx.doi.org/10.1073/pnas.2005615117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245089/
https://www.ncbi.nlm.nih.gov/pubmed/32350134
http://dx.doi.org/10.1073/pnas.2005615117

Ejemplares similares